Members
-
Iain Inkster admin
External News
Project Description
On this page our external news editor, Iain Inkster, highlights a range of news reports and articles of interest and relevance to SENS Foundation's mission.
Project News & Updates
Embryonic stem cell trials for macular degeneration
On Monday, The Lancet medical journal published a paper on trials at UCLA in which hESC-derived cells were transplanted into human patients, with positive results for sufferers of macular degeneration. Parallel trials are currently taking place in the UK at Moorfields Eye Hospital in London.
Proceed to the article at The Lancet.
Researchers Target, Clear Senescent Cells in Mice
The Mayo Clinic has recently published exciting results from an independent research project it conducted with collaborators at the University of Groningen in the journal Nature. The project successfully demonstrated that the clearance of senescent cells can delay the onset of adverse age-related changes, such as muscle loss, in mice that have been genetically engineered to age at an increased rate. This represents the finest proof of concept work to date on the effectiveness of senescent cell removal in countering the effects of aging.
Proceed to the article at Nature.
Age-Related Diseases: Medicine's Final Adversary?
SENS Foundation's CSO's has submitted a fresh introductory overview and status update of SENS, as part of a series of covering the various fundamental aspects of age-related infirmity.
Proceed to the article at AOL Healthy Living/Huffington Post.
Regenerative Medicine Institute to continue getting state funds
For more information on our titular collaborators, see .
Proceed to the article at JournalNow.Com.
Lab-grown brain cells should aid research into Alzheimer's
Good article, and interesting comments after the first few lines of bickering.
Proceed to the article at BBC News.
Funding crisis hits US ageing research
The dismal odds of winning an NIA-funded grant "threaten the viability of ageing research" says Richard Hodes, the NIA's director. "If we are less able to fund research — or are perceived to be less able — that will actually drive young and emerging investigators to fields other than ageing. That would be a catastrophe at a time when such research is critically important."
Proceed to the article at Nature.
Southern California Public Radio
Our CSO Aubrey de Grey partakes in an interesting debate concerning the theoretical consequences of radical life extension. The debate is way up high on the ivory tower, but worth a listen.
Proceed to the article at Southern California Public Radio.
El Ser Creativo
El Ser Creativo, to be held in Málaga on October 21st-23rd, is focused on great ideas and ways of sharing them. Dr Aubrey de Grey is one of the 25 speakers who will present and answer questions on their work and ideas, and their implications for society.
Proceed to the article at El Ser Creativo.
5th World Congress on Preventive & Regenerative Medicine
The World Congress on Preventive & Regenerative Medicine, hosted this year in Hannover from October 5th-7th, is the only international event addressing the entire regenerative medicine sector. This broad remit, similar to that of the SENS conference series, gives the meeting outstanding potential to foster interdisciplinary collaborations in research and development.
Proceed to the article at World Congress on Preventive & Regenerative Medicine.
World Stem Cell Summit 2010
The World Stem Cell Summit - hosted this year in Detroit, Michigan from October 4th to 6th - is a wide-ranging event covering topics from basic research to social policy and ethics, and expected this year to attract more than 1,200 delegates from 30 nations.
Proceed to the article at World Stem Cell Summit.
InnoCentive and SENS Foundation Seek Innovative Ideas to Help Reverse Age Related Illnesses
For SENSF's comments on the subject, see the lefthand news column on the homepage.
Proceed to the article at Sys-con.com.
Long for this World -- New York Times review
http://www.nytimes.com/2010/08/01/books/review/Verghese-t.html
Proceed to the article at New York Times.
Singularity Summit 2010
From the summit website:
Proceed to the article at Singularity Summit.
Moral, philosophical questions dog scientists' efforts to repair cells, clear body's garbage'
This article contains an interesting review of a new philosophical work centred mainly around the SENS effort.
I have not had a chance to read the book yet, but the descriptions of its content give me mixed feelings.
Firstly, it seems fairly well researched. The description of the SENS strategy in the book, which made its way into the reviews (e.g. the stuff about removing cellular garbage), suggests that the author is under no illusions about what the SENS approach is.
Proceed to the article at Istockanalyst (from Kansas City Star).
Open Science Summit 2010
From July 29-31 at Berkeley's I-House, longtime longevity advocate Joseph Jackson is hosting the Open Science Summit. This is the first conference to bring together the many entities working to transform the institutions and practices that comprise or science + innovation system. Much more information is available in his recent interview with h+ magazine.
Proceed to the article at opensciencesummit.com.
Aubrey de Grey at How The Light Gets In
How The Light Gets In is a festival of philosophy and music, taking place this year in Hay-on-Wye from May 28th to June 6th. The event promises a remarkable line-up of leading thinkers mixed with cutting edge musicians and performers.
Dr. de Grey will participate in the panel session entitled "Mortality and Immortality", hosted in association with the Wellcome Trust's Identity Project.
Proceed to the article at HowTheLightGetsIn.
UK Guardian on ethics of life extension
I don't like the tone of this article, which rants about immortality and then precipitates the same old tired and tawdry debate about wanting to 'live forever'. I feel it fails to treat the subject with the respect it deserves.
The truly relevant ethical question before us, concerning the ethics of life extension, is:
Given that everybody ages, for whose benefit do we age?
Proceed to the article at The Guardian.
The FDA and Methuselah
This article explicitly describes the SENS approach right from the outset, contrasting it with former approaches. This is an encouraging development in the mainstream press coverage of SENS, which usually begins by introducing the prospect of extreme longevity, only mentioning the method parenthetically.
Proceed to the article at Forbes.Com.
